Henry Brem

Active 1974–2025

167
Papers
32,118
Citations
92
h-index
162
i10-index

Citations

Citations per year for Henry Brem1974: 1 citations1975: 1 citations1976: 1 citations1977: 5 citations1978: 11 citations1979: 5 citations1980: 14 citations1981: 4 citations1982: 8 citations1983: 6 citations1984: 3 citations1985: 4 citations1986: 1 citations1987: 4 citations1988: 6 citations1989: 4 citations1990: 11 citations1991: 12 citations1992: 13 citations1993: 12 citations1994: 43 citations1995: 52 citations1996: 53 citations1997: 79 citations1998: 61 citations1999: 71 citations2000: 55 citations2001: 59 citations2002: 117 citations2003: 90 citations2004: 94 citations2005: 117 citations2006: 195 citations2007: 169 citations2008: 190 citations2009: 186 citations2010: 201 citations2011: 196 citations2012: 211 citations2013: 199 citations2014: 239 citations2015: 376 citations2016: 378 citations2017: 372 citations2018: 342 citations2019: 1,070 citations2020: 1,334 citations2021: 1,197 citations2022: 987 citations2023: 649 citations2024: 1,001 citations2025: 460 citations2026: 12 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,842 citing papers, 30.4% of this breakdownChina: 1,517 citing papers, 12% of this breakdownGermany: 699 citing papers, 5.5% of this breakdownItaly: 643 citing papers, 5.1% of this breakdownUnited Kingdom: 612 citing papers, 4.8% of this breakdownFrance: 459 citing papers, 3.6% of this breakdownCanada: 360 citing papers, 2.9% of this breakdownIndia: 332 citing papers, 2.6% of this breakdownAustralia: 302 citing papers, 2.4% of this breakdownSpain: 297 citing papers, 2.4% of this breakdownNetherlands: 295 citing papers, 2.3% of this breakdownJapan: 290 citing papers, 2.3% of this breakdown
0%30.4%Other 23.7%

Fields

  • Medicine46.7%
  • Biochemistry, Genetics and Molecular Biology31%
  • Materials Science6.2%
  • Engineering4.5%
  • Immunology and Microbiology4.4%
  • Neuroscience3%
  • Other4.2%

Topics

  • Glioma Diagnosis and Treatment8.9%
  • Cancer Genomics and Diagnostics7.1%
  • Cancer Immunotherapy and Biomarkers3%
  • Cancer Cells and Metastasis2.8%
  • Brain Metastases and Treatment2.8%
  • Nanoparticle-Based Drug Delivery2.7%
  • Other72.7%

Coauthors

All papers

Open in search
  1. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Calogero Lauricella, Michael Lim, Evan J. Lipson, Suely Kazue Nagahashi Marie, George J. Netto, Kelly S. Oliner, Alessandro Olivi, Louise Olsson, Gregory J. Riggins, Andrea Sartore‐Bianchi, Kerstin Schmidt, le-Ming Shih, Sueli Mieko Oba‐Shinjo, Salvatore Siena, Dan Theodorescu, Jeanne Tie, Timothy T. Harkins, Silvio Veronese, Tian‐Li Wang, Jon Weingart, Christopher L. Wolfgang, Laura D. Wood, Dongmei Xing, Ralph H. Hruban, Jian Wu, Peter J. Allen, C. Max Schmidt, Michael A. Choti, Victor E. Velculescu, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Luis A. Díaz - Science Translational Medicine 2014 cited by 5,110

  2. Polylactic acid (PLA) controlled delivery carriers for biomedical applications

    Authors: , , , , - Advanced Drug Delivery Reviews 2016 cited by 1,028

  3. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephanie E. Weiss, Patrick Y. Wen, Nicole E. Willmarth, Mary Anne Bergman, Susan Darlow - Journal of the National Comprehensive Cancer Network 2020 cited by 564

  4. Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas

    Authors: , , , , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2013 cited by 898

  5. Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2016 cited by 463

  6. TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM

    Authors: , , , , , , , , , , , , , , , , , , , , , , - OncoImmunology 2018 cited by 333

  7. Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chetan Bettegowda - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 474

  8. Paclitaxel: a review of adverse toxicities and novel delivery strategies

    Authors: , , , , , - Expert Opinion on Drug Safety 2007 cited by 510

  9. Self-assembling paclitaxel-mediated stimulation of tumor-associated macrophages for postoperative treatment of glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 68

  10. Expression of LAG‐3 and efficacy of combination treatment with anti‐LAG‐3 and anti‐PD‐1 monoclonal antibodies in glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , - International Journal of Cancer 2018 cited by 159

  11. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas

    Authors: , , , , , , , , , , , , - The Lancet 1995 cited by 1,382

  12. Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma

    Authors: , , , , , , , , , , , , , , , - Neuro-Oncology 2013 cited by 494

  13. Anti–PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM

    Authors: , , , , , , , , , , , , , , , , , - Science Translational Medicine 2016 cited by 300

  14. Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment

    Authors: , , , , , , , , , , , , , , , , - Journal of Neuro-Oncology 2019 cited by 147

  15. Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response

    Authors: , , , , , , , , , , , - PLoS ONE 2015 cited by 205

  16. P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression

    Authors: , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 78

  17. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells

    Authors: , , , , , , , , , - Nature 2006 cited by 1,174

  18. Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo

    Authors: , , , , , , , , , , , , , , , , , - ACS Nano 2015 cited by 252

  19. NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christina Tsien, Stephanie E. Weiss, Patrick Y. Wen, Nicole E. Willmarth, Mary Anne Bergman, Anita M. Engh - Journal of the National Comprehensive Cancer Network 2017 cited by 231

  20. Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma

    Authors: , , , , , , , , , , , , , , , - OncoImmunology 2021 cited by 48

  21. The cytokine Meteorin-like inhibits anti-tumor CD8+ T cell responses by disrupting mitochondrial function

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Lim - Immunity 2024 cited by 43

  22. MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression

    Authors: , , , , , , , , , , , , , , , , , , , , - JCI Insight 2022 cited by 29

  23. Convection enhanced delivery of cisplatin-loaded brain penetrating nanoparticles cures malignant glioma in rats

    Authors: , , , , , , , , , - Journal of Controlled Release 2017 cited by 129

  24. Independent association of extent of resection with survival in patients with malignant brain astrocytoma

    Authors: , , , , , , , , - Journal of neurosurgery 2008 cited by 814